Searching for
guideline-recommended
genomic information?

Get results faster.

Guide treatment decisions in 7 days
with Liquid Biopsy.

Consistently High
Concordance with Tissue

for targetable alterations before first-line NSCLC therapy1

Consistently High
Concordance with Tissue

  • Best-in-class detection
  • Unparalleled validation of clinical sensitivity and specificity

Tissue has limitations beyond your control

  • Treatment delays
  • Patient burden
  • Finite resource
  • Practice/staff burden

Relying solely
on tissue leads to
undergenotyping

~ 1 in 2 NSCLC patients are unable to get
guideline-recommended
genes for NSCLC2-6

EGFR
ALK
ROSI
BRAF
MET
RET
ERBB2 (HER2)
NTRK

When to use
Guardant360

  • Before 1st Line Treatment

    Get ahead of the challenges of tissue testing in advanced NSCLC by utilizing Guardant360 to guide 1L treatment decisions

  • At Progression

    Get genomic information on over 70+ genes relevant across multiple solid tumors including MSI-High to help find pan cancer therapies and clinical trials.

Published Data

Prospective study of 323 NSCLC patients found Guardant360 improved alteration detection1

44% of eligible patients

were unable to get complete genomic results from tissue biopsy

2x as many patients

had targetable alterations detected by Guardant360 and tissue testing (n=82) versus tissue testing alone (n=47)

86% of patients

had a response or stable disease based on RECIST criteria

Results in 7 Days
to Guide Treatment

Easy to interpret report informs first-line decisions and beyond

Test

with Guardant360 when patient is diagnosed with advanced NSCLC

Get results
in 7 days

to guide treatment
decisions

Take action

with first-line
treatment

Everything you need
to get started

PHYSICIAN PORTAL

PHYSICIAN PORTAL

App Store
  • End-to-end support to manage billing

  • On-call support for MD’s and patients

  • Easy access to reports via fax, online portal, or app

  • Medicare coverage for advanced NSCLC

  • Advanced Beneficiary Notice

Guardant Access manages
the billing process for your patients

  • Insurance & eligibility confirmation

    Insurance eligibility confirmation and patient outreach if patient out-of-pocket cost exceeds $100 for all patients

  • Easy enrollment

    Any patient can enroll for financial assistance eligibility determination by signing the back of the Test Requisition Form or contacting Guardant Health Client Services